VAV to support academic research in lipid nanomedicine
The company has announced a slew of research benefits to universities and academic institutions around the world that take up…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
VAV Life Sciences
VAV Life Sciences receives COSMOS approval from Ecocert for cosmetics ingredients
The COSMOS approval will allow VAV’s natural cosmetics ingredients to be marketed and commercialised worldwide
VAV expands capacity for COVID-19 lipids
The company invests Rs 15 crores to boost capacity to meet overseas demand for specialised lipids used in COVID-19 vaccines and…
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across…
Supplied lipids for about three lakh vials of Amphotericin B formulations: VAV Life Sciences
VAV expects to triple the quantity by December 2021
VAV Life Sciences ramps up production of crucial lipid ingredients needed for amphotericin-B
VAV expects with an increased capacity, its lipid raw materials will help pharma companies to add three lakh vials of liposomal…